top of page

Canagliflozin for Type 2 Diabetes - reduces cardiovascular events.

Canagliflozin for Type 2 Diabetes - reduces cardiovascular events.

Canagliflozin reduces major adverse cardiovascular events (MACE) in patients with T2DM. Big paper in the NEJM, (the trials sponsored by...

Featured Posts

Keep Yourself Healthy during Coronavirus

Keep Yourself Healthy during Coronavirus

Graves' thyrotoxicosis information for patients & their doctors

Graves' thyrotoxicosis information for patients & their doctors

Thyroid Medications - Carbimazole & Propylthiouracil Advice for Patients

Thyroid Medications - Carbimazole & Propylthiouracil Advice for Patients

Menopause - Listen to Your Patients

Menopause - Listen to Your Patients

Type 2 Diabetes, Heart Attacks, Stroke and Heart Failure - How Can I Reduce My Risk?

Heavy periods - menorrhagia, what can I do about them?

Heavy periods - menorrhagia, what can I do about them?

Graves Hyperthyroidism - information for patients

Graves Hyperthyroidism - information for patients

Excess Sweating - Hyperhidrosis

Excess Sweating - Hyperhidrosis

Breast Cancer - ovarian function, oestrogen, fertility and the menopause

Breast Cancer - ovarian function, oestrogen, fertility and the menopause

Menopause - general diagnostic advice for professionals and patients

Menopause - general diagnostic advice for professionals and patients

Recent Posts

Vitamin D - do you need it for your heart?

Parkinson's and Movement Disorders

Post-Partum/ Post-Pregnancy Thyroiditis

Safe Prescribing and Communication on Your Care

Keep Yourself Healthy during Coronavirus

Testosterone and The Menopause

Graves' thyrotoxicosis information for patients & their doctors

Lowering Liver Fat

T2DM Update - Major Therapeutic Advance - New Oral Treatment for Type 2 Diabetes.

Mental Health - It is OK to Not Be OK

Archive

Search By Tags

Follow Us

bottom of page